Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons

Core Viewpoint - The article discusses serious adverse events related to COVID-19 vaccines, particularly focusing on the Pfizer/BioNTech and Moderna trials, highlighting issues with trial protocols and regulatory oversight [1][2][3]. Group 1: Vaccine Trials and Regulatory Oversight - The Pfizer and Moderna vaccines received Emergency Use Authorization (EUA) after only 20 weeks of testing, which is atypical for vaccine trials [2]. - A forensic review of 38 deaths during the Pfizer vaccine trial revealed that regulators were not informed of two deaths, including one possibly linked to "sudden cardiac death," which could have influenced the approval process [3]. - The authors argue that had accurate data been presented to the FDA's Advisory Committee, it would have been evident that the vaccine did not save lives [3]. Group 2: Data Discrepancies and Health Risks - The article highlights a 3.7-fold increase in cardiac events among subjects receiving the BNT162b2 vaccine compared to the placebo, indicating significant data discrepancies [4]. - By the time the FDA and CDC acknowledged increased risks of myocarditis and pericarditis, many teenagers had already been vaccinated, with the risks downplayed to parents [5]. Group 3: Recommendations for Regulatory Reform - The authors conclude that restoring public trust in regulatory agencies requires significant policy changes, including the repeal of the PREP Act to prevent inadequately tested treatments from being administered [6].